Leah Strickling
About Leah Strickling
Leah Strickling serves as the Associate Director of Corporate Development & Strategy at Nimbus Therapeutics, a position she has held since 2023. She has a diverse background in corporate strategy and medical affairs, with previous roles at Valo, Merck Group, and Back Bay Life Science Advisors.
Current Role at Nimbus Therapeutics
Leah Strickling serves as the Associate Director of Corporate Development & Strategy at Nimbus Therapeutics. She has held this position since 2023 and is based in Boston, Massachusetts. In her role, she is involved in strategic initiatives that support the company's corporate development efforts.
Previous Experience at Valo
Leah Strickling worked at Valo from 2021 to 2023. Initially, she served as Senior Manager of Corporate Strategy for one year before transitioning to Associate Director of Corporate Strategy, a position she held for ten months. Her tenure at Valo contributed to her expertise in corporate strategy within the life sciences sector.
Experience at Back Bay Life Science Advisors
Leah Strickling was associated with Back Bay Life Science Advisors in various roles from 2017 to 2021. She began as an Analyst, later advancing to Consultant and then Senior Consultant. Her work spanned a total of three years, focusing on strategic consulting for life sciences clients in the Greater Boston Area.
Background in Medical Affairs at Merck Group
Leah Strickling's experience at Merck Group included two roles in Global Medical Affairs. In 2016, she worked as an Associate in Oncology for four months. In 2017, she held a position as Associate in Global Business Franchise, focusing on Neurology & Immunology, also for four months. These roles provided her with insights into medical affairs and product strategy.
Education in Pharmacology
Leah Strickling earned her Bachelor of Science (B.Sc.) in Pharmacology from McGill University, where she studied from 2012 to 2016. Her educational background equips her with a strong foundation in the biological sciences, relevant to her career in corporate strategy within the life sciences industry.